ECSP003672A - SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES - Google Patents

SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES

Info

Publication number
ECSP003672A
ECSP003672A ECSP003672A ECSP003672A EC SP003672 A ECSP003672 A EC SP003672A EC SP003672 A ECSP003672 A EC SP003672A EC SP003672 A ECSP003672 A EC SP003672A
Authority
EC
Ecuador
Prior art keywords
app
secretase
alzheimer
disease
substrates
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Mark E Gurney
Michael J Bienkowski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP003672 priority Critical patent/ECSP003672A/en
Publication of ECSP003672A publication Critical patent/ECSP003672A/en

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

La presente invención proporciona la enzima y los procedimientos enzimáticos para escindir el sitio de escición de a-secretasa de la proteína APP, y los correspondientes ácidos nucleicos, péptidos, vectores, células y aislados celulares y ensayos. También se proporciona una enzima que corta el sitio a-secretasa de APP. La invención además proporciona una proteína APP modificada y sus correspondientes ácidos nucleicos, péptidos, vectores, células y aislados celulares, y ensayos que son esencialmente útiles para identificar sustancias potencialmente terapéuticas en el tratamiento o la prevención de la enfermedad de Alzheimer.The present invention provides the enzyme and enzymatic methods for cleaving the a-secretase cleavage site of the APP protein, and the corresponding nucleic acids, peptides, vectors, cells and cell isolates and assays. An enzyme that cuts the APP-secretase site of APP is also provided. The invention further provides a modified APP protein and its corresponding nucleic acids, peptides, vectors, cells and cell isolates, and assays that are essentially useful for identifying potentially therapeutic substances in the treatment or prevention of Alzheimer's disease.

ECSP003672 2000-09-22 2000-09-22 SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES ECSP003672A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP003672 ECSP003672A (en) 2000-09-22 2000-09-22 SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP003672 ECSP003672A (en) 2000-09-22 2000-09-22 SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES

Publications (1)

Publication Number Publication Date
ECSP003672A true ECSP003672A (en) 2001-04-23

Family

ID=42041266

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP003672 ECSP003672A (en) 2000-09-22 2000-09-22 SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES

Country Status (1)

Country Link
EC (1) ECSP003672A (en)

Similar Documents

Publication Publication Date Title
AR025754A1 (en) SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES
ATE420185T1 (en) ALZHEIMER'S DISEASE SECRETASIS
WO2001049097A3 (en) Alzheimer's disease secretase, app substrates therefor, and uses therefor
AR012351A1 (en) A METHOD AND DEVICES FOR DIVIDING LIQUID BIOLOGICAL SAMPLES IN MICROVOLUMES
DE60238058D1 (en) USE OF LYSYLOXYDEASE INHIBITORS FOR CELL CULTURE AND TISSUE STRUCTURE
DE60238493D1 (en) IS OF RARE CELLS USED MARKED CELLS
ATE219380T1 (en) VEHICLES FOR INTRODUCING NUCLEIC ACIDS INTO CELLS
TR199801794T2 (en) How long has it been?
ATE353974T1 (en) METHODS, COMPOSITIONS AND KITS FOR IDENTIFYING AND MONITORING BREAST CANCER
ECSP045520A (en) TREATMENT METHODS WITH PTEC INHIBITORS AND ANTIHIPERTENSIVE AGENTS
ATE360808T1 (en) INDEPENDENT DEVICE FOR EXTRACTION, AMPLIFICATION AND DETECTION OF NUCLEIC ACIDS
ATE437652T1 (en) USE OF HMGB1 TO ACTIVATE DENDRITIC CELLS
DE3587875D1 (en) RECOMBINANT METHOD FOR THE PRODUCTION OF SERINE PROTEASE INHIBITORS, AND DNA SEQUENCES THEREFOR.
DE69932845D1 (en) METHODS OF QUANTIFYING HLA-DR AND CD11B
DE69734974D1 (en) METHOD OF TRANSFORMATIONING DENDRITIC CELLS AND ACTIVATING T CELLS
NZ513923A (en) Methods for detecting membrane derived caspase activity and modulators thereof
DE50107766D1 (en) TWO-TONE FLUORIMETRIC PROTEASE ASSAY
ECSP003672A (en) SECRETASE IN THE DISEASE OF ALZHEIMER, SUBSTRATES OF THE APP AND ITS USES
Yamaguchi et al. Characterization of regucalcin effect on proteolytic activity in rat liver cytosol: relation to cysteinyl-proteases
DE69836862D1 (en) DEVICE FOR CUTTING BIOPSY OF MAMMA TISSUE
ES2161856T3 (en) FUSION ENZYME OF A TYROSINE AND AN ACTIVATING PROTEIN.
DE60225587D1 (en) PROTEASE ASSAY TO CONTROL MEDICINAL THERAPY
CY1110496T1 (en) ALZHEIMER DISEASE SECRET, THIS APP SUBSTANCES, AND USE OF THIS
WO1999001567A3 (en) Methods and compositions for a deubiquitinating enzyme and variants thereof
BR9811181A (en) Process to influence the binding of a p53 to a target gene